Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson’s disease

被引：2
|
作者：
Ilona Joniec-Maciejak
Adriana Wawer
Danuta Turzyńska
Alicja Sobolewska
Piotr Maciejak
Janusz Szyndler
Dagmara Mirowska-Guzel
Adam Płaźnik
机构：
[1] Medical University of Warsaw,Department of Experimental and Clinical Pharmacology
[2] Centre for Preclinical Research and Technology (CePT),Department of Neurochemistry
[3] Institute of Psychiatry and Neurology,undefined
来源：
Pharmacological Reports | 2018年 / 70卷
关键词：
Parkinson’s disease; Octanoic acid; MPTP; PGC-1α; PEPCK;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：988 / 992
页数：4
相关论文
共 50 条
  • [21] Behavioral characterization in MPTP/p mouse model of Parkinson's disease
    Wada, Mai
    Ang, Mary Jasmin
    Weerasinghe-Mudiyanselage, Poornima D. E.
    Kim, Sung-Ho
    Kim, Jong-Choon
    Shin, Taekyun
    Moon, Changjong
    JOURNAL OF INTEGRATIVE NEUROSCIENCE, 2021, 20 (02) : 307 - 320
  • [22] Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
    Cornelius J. H. M. Klemann
    Gerard J. M. Martens
    Geert Poelmans
    Jasper E. Visser
    Molecular Neurobiology, 2016, 53 : 1625 - 1636
  • [23] MPTP Mouse Model of Preclinical and Clinical Parkinson's Disease as an Instrument for Translational Medicine
    Mingazov, Eduard R.
    Khakimova, Gulnara R.
    Kozina, Elena A.
    Medvedev, Alexei E.
    Buneeva, Olga A.
    Bazyan, Ara S.
    Ugrumov, Michael V.
    MOLECULAR NEUROBIOLOGY, 2018, 55 (04) : 2991 - 3006
  • [24] Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease
    Perez-H, Jesus
    Carrillo-S, Carlos
    Garcia, Esperanza
    Ruiz-Mar, Gabriela
    Perez-Tamayo, Ruy
    Chayarria, Anahi
    TOXICOLOGY, 2014, 319 : 38 - 43
  • [25] Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease
    Zhang, Lingling
    Huang, LinHong
    Chen, Liangwei
    Hao, Dingjun
    Chen, Jianzong
    TOXICOLOGY LETTERS, 2013, 222 (02) : 155 - 163
  • [26] Rescue of dying neurons by (R)-deprenyl in the MPTP-mouse model of Parkinson's Disease does not include restoration of neostriatal dopamine
    Steyn, SJ
    Castagnoli, K
    Castagnoli, N
    NEUROPROTECTIVE AGENTS, 2001, 939 : 330 - 339
  • [27] Neurochemical findings in the MPTP model of Parkinson's disease
    Schmidt, N
    Ferger, B
    JOURNAL OF NEURAL TRANSMISSION, 2001, 108 (11) : 1263 - 1282
  • [28] MPTP as a Mitochondrial Neurotoxic Model of Parkinson's Disease
    Serge Przedborski
    Kim Tieu
    Celine Perier
    Miquel Vila
    Journal of Bioenergetics and Biomembranes, 2004, 36 : 375 - 379
  • [29] Amiloride is neuroprotective in an MPTP model of Parkinson's disease
    Arias, Robert L.
    Sung, Mei-Li A.
    Vasylyev, Dmytro
    Zhang, Mei-Yi
    Albinson, Kristin
    Kubek, Katie
    Kagan, Natasha
    Beyer, Chad
    Lin, Qian
    Dwyer, Jason M.
    Zaleska, Margaret M.
    Bowlby, Mark R.
    Dunlop, John
    Monaghan, Michael
    NEUROBIOLOGY OF DISEASE, 2008, 31 (03) : 334 - 341
  • [30] Neurochemical findings in the MPTP model of Parkinson's disease
    N. Schmidt
    B. Ferger
    Journal of Neural Transmission, 2001, 108 : 1263 - 1282
12345